These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [The infection and immunity of HIV: hope and thought]. Shang H Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):220-2. PubMed ID: 17425861 [No Abstract] [Full Text] [Related]
43. Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection. Fouts TR; Bagley K; Prado IJ; Bobb KL; Schwartz JA; Xu R; Zagursky RJ; Egan MA; Eldridge JH; LaBranche CC; Montefiori DC; Le Buanec H; Zagury D; Pal R; Pavlakis GN; Felber BK; Franchini G; Gordon S; Vaccari M; Lewis GK; DeVico AL; Gallo RC Proc Natl Acad Sci U S A; 2015 Mar; 112(9):E992-9. PubMed ID: 25681373 [TBL] [Abstract][Full Text] [Related]
45. How should the potency of HIV vaccine candidates be determined? Sheets R; Bean P Am Clin Lab; 2000; 19(8):23. PubMed ID: 11146989 [No Abstract] [Full Text] [Related]
46. An anti-idiotype vaccine for AIDS based on the HIV receptor. Dalgleish AG Ann Ist Super Sanita; 1991; 27(1):27-31. PubMed ID: 1683525 [TBL] [Abstract][Full Text] [Related]
47. The prospects for vaccines against HIV-1: more than a field of long-term nonprogression? Sheppard N; Sattentau Q Expert Rev Mol Med; 2005 Feb; 7(2):1-21. PubMed ID: 15710051 [TBL] [Abstract][Full Text] [Related]
48. Potential pitfalls on the road to an effective HIV vaccine. Schwartz DH Immunol Today; 1994 Feb; 15(2):54-7. PubMed ID: 7908803 [TBL] [Abstract][Full Text] [Related]
49. A simplified vaccinologists' vaccinology and the pursuit of a vaccine against AIDS. Hilleman MR Vaccine; 1998 May; 16(8):778-93. PubMed ID: 9627935 [TBL] [Abstract][Full Text] [Related]
51. Is there any room for therapeutic vaccination against the HIV-1/AIDS? Iglesias E Hum Vaccin Immunother; 2013 Jul; 9(7):1539-44. PubMed ID: 23571171 [TBL] [Abstract][Full Text] [Related]
52. Human immunodeficiency virus antibodies and the vaccine problem. Chiodi F; Weiss RA J Intern Med; 2014 May; 275(5):444-55. PubMed ID: 24581142 [TBL] [Abstract][Full Text] [Related]
53. Multiple Approaches for Increasing the Immunogenicity of an Epitope-Based Anti-HIV Vaccine. Rosa DS; Ribeiro SP; Fonseca SG; Almeida RR; Santana VC; Apostólico Jde S; Kalil J; Cunha-Neto E AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1077-88. PubMed ID: 26149745 [TBL] [Abstract][Full Text] [Related]
54. [Development of HIV vaccines]. Shibata R Nihon Rinsho; 2002 Apr; 60(4):790-7. PubMed ID: 11968790 [TBL] [Abstract][Full Text] [Related]
55. What are the correlates of protection? Cohen J Science; 1993 May; 260(5112):1259. PubMed ID: 8493565 [No Abstract] [Full Text] [Related]
56. Autoimmunity and dysmetabolism of human acquired immunodeficiency syndrome. Huang YM; Hong XZ; Xu JH; Luo JX; Mo HY; Zhao HL Immunol Res; 2016 Jun; 64(3):641-52. PubMed ID: 26676359 [TBL] [Abstract][Full Text] [Related]
57. CD8+ T-cells: are they sufficient to prevent, contain or eradicate HIV-1 infection? Brown SA; Hurwitz JL; Zhan X; Doherty PC; Slobod KS Curr Drug Targets Infect Disord; 2005 Jun; 5(2):113-9. PubMed ID: 15975017 [TBL] [Abstract][Full Text] [Related]
58. [Secondary prevention of AIDS]. DomÃnguez Carmona M An R Acad Nac Med (Madr); 1996; 113(2):371-410; discussion 411-2. PubMed ID: 9072920 [No Abstract] [Full Text] [Related]
59. Premature ageing of the immune system: the cause of AIDS? Appay V; Rowland-Jones SL Trends Immunol; 2002 Dec; 23(12):580-5. PubMed ID: 12464569 [TBL] [Abstract][Full Text] [Related]
60. HIV and AIDS. Allen AD; Mathisen GE; Glover N; Au J Science; 1993 Jun; 260(5115):1706-7. PubMed ID: 8099760 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]